JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ATNM - Actinium Pharmaceuticals, Inc.
USD | NYSE | Healthcare
Summary
Summary ATNM Stock
Financials
Financials ATNM Stock
Loading...
Loading...
Income Statement
Income Statement ATNM Stock
Balance Sheet
Balance Sheet ATNM Stock
Cash Flow Statement
Cash Flow Statement ATNM Stock
Loading...
Loading...
ATNM Financials - Actinium Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Actinium Pharmaceuticals, Inc. (ATNM)
Financials
Financials of ATNM
Loading...
Loading...
Loading...
Loading...
Revenue
$90K
Operating Income
$-36.247M
Net Income
$-33.887M
Share Count (Basic)
31.195891M
Operating Cash Flow
$-24.58M
Free Cash Flow
$-24.684M
Cash And Short-Term Equivalents
$47.998M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
200K
400K
600K
800K
1M
1.2M
FY2021
FY2022
FY2023
Revenue $USD
0
20K
40K
60K
80K
Q3 FY25
Annual
Quarterly
Net Income $USD
-50M
-45M
-40M
-35M
-30M
-25M
Annual
Quarterly
Margins
Gross
Operating
Net
-60000%
-40000%
-20000%
0%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-16M
-14M
-12M
-10M
-8M
-6M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-6200%
-6000%
-5800%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26